Successful Aging and Age-related Decline
MyAgeWell
Successful Ageing: Evidence-based Interventions to Delay Ageing-related Decline
1 other identifier
interventional
400
1 country
1
Brief Summary
Recent studies have shown promising cognitive and physical interventions aimed at slowing down ageing-related declines in quality of life, but they lack strong ecological validity (brief durations, unrealistic goals, no real-world application) and has yet to show robust evidence that such interventions are stable and suitable in the long-term. The investigators aim to examine whether these interventions can, over four years, significantly slow down the normal rate of ageing-related decline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2022
CompletedFirst Submitted
Initial submission to the registry
April 3, 2024
CompletedFirst Posted
Study publicly available on registry
April 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2030
April 19, 2024
April 1, 2024
7 years
April 3, 2024
April 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Changes in cognitive scores
Changes in cognitive scores will be evaluated using Montreal Cognitive Assessment (MoCA). Possible scores range from 0-30. Higher scores indicate less cognitive impairment.
4 years
Changes in electroencephalogram (EEG)
Onset of neural responses to errors in the Go/No Go task will be evaluated using EEG.
4 years
Changes in structural magnetic resonance imaging (MRI)
Relationship between Wisconsin Card Sorting Test performance and grey matter volume will be evaluated using structural MRI.
4 years
Cost-benefit analysis of intervention
The economic benefits from the interventions will be evaluated and will cover three aspects: financial, productivity and health.
4 years
Changes in levels of human salivary lactoferrin
Changes in levels of human salivary lactoferrin (ng/mL) will be measured using salivary Enzyme-Linked Immunosorbent Assay (ELISA) kits. Low levels of lactoferrin can potentially indicate higher risk for cognitive impairment.
4 years
Changes in levels of human salivary C-reactive proteins
Changes in levels of human salivary C-reactive proteins (CRP, mg/L) will be measured using salivary Enzyme-Linked Immunosorbent Assay (ELISA) kits. High levels of CRP can indicate inflammation and its association with greater cognitive decline.
4 years
Changes in salivary telomere length
Changes in salivary telomere length (T/S ratio) will be measured using quantitative PCR. A higher T/S ratio indicates better preservation of telomere length hence better preservation of cognition.
4 years
Secondary Outcomes (2)
Changes in depression scores
4 years
Changes in anxiety scores
4 years
Study Arms (4)
Cognitive stimulation
EXPERIMENTALParticipants will take part in psychoeducation, videogaming, book club and technology training workshops.
Physical activity
EXPERIMENTALParticipants will take part in walking, Zumba, resistance exercise and aerobics sessions.
Combined intervention
EXPERIMENTALParticipants will take part in both cognitive stimulation and physical activity intervention sessions.
Non-intervention control
NO INTERVENTIONParticipants will not take part in any intervention.
Interventions
The cognitive stimulation will comprise of psychoeducation, videogaming, book club and technology training workshop sessions. Participants will take part in weekly sessions that are an hour long each. For every six months, the participants will alternate between psychoeducation, videogaming, book club and technology training workshop sessions.
The physical activity intervention will comprise of walking, Zumba, resistance exercise and aerobics sessions. Participants will take part in weekly sessions that are an hour long each. For every six months, the participants will alternate between walking, Zumba, resistance exercise and aerobics sessions until the end of intervention period.
Eligibility Criteria
You may qualify if:
- Healthy and this includes those seeking regular medical attention,
- Have some form of mobility (ability to walk short distances at least 3m),
- Able to communicate in at least one of the following languages: English, Malay, Mandarin, Tamil.
You may not qualify if:
- Older adults with a history of stroke,
- Diagnosis of neurodegenerative diseases (such as Alzheimer's disease or Parkinson's) or psychiatric disorders,
- Uncorrected auditory and/or visual impairments,
- Currently on psychiatric medications,
- Immobile,
- Require full-time caregiver assistance,
- With comprehension impediments from the assessment portion of this project,
- A Montreal Cognitive Assessment (MoCA) score of \<13.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunway University
Petaling Jaya, Selangor, 47500, Malaysia
Related Publications (6)
Bogataj S, Mesaric KK, Pajek M, Petrusic T, Pajek J. Physical exercise and cognitive training interventions to improve cognition in hemodialysis patients: A systematic review. Front Public Health. 2022 Oct 14;10:1032076. doi: 10.3389/fpubh.2022.1032076. eCollection 2022.
PMID: 36311587BACKGROUNDErickson KI, Leckie RL, Weinstein AM. Physical activity, fitness, and gray matter volume. Neurobiol Aging. 2014 Sep;35 Suppl 2:S20-8. doi: 10.1016/j.neurobiolaging.2014.03.034. Epub 2014 May 14.
PMID: 24952993BACKGROUNDMurman DL. The Impact of Age on Cognition. Semin Hear. 2015 Aug;36(3):111-21. doi: 10.1055/s-0035-1555115.
PMID: 27516712BACKGROUNDOgawa T, Hirose Y, Honda-Ogawa M, Sugimoto M, Sasaki S, Kibi M, Kawabata S, Ikebe K, Maeda Y. Composition of salivary microbiota in elderly subjects. Sci Rep. 2018 Jan 11;8(1):414. doi: 10.1038/s41598-017-18677-0.
PMID: 29323208BACKGROUNDWells PM, Sprockett DD, Bowyer RCE, Kurushima Y, Relman DA, Williams FMK, Steves CJ. Influential factors of saliva microbiota composition. Sci Rep. 2022 Nov 7;12(1):18894. doi: 10.1038/s41598-022-23266-x.
PMID: 36344584BACKGROUNDYong MH, Lawrie L, Schaefer A, Phillips LH. The Effects of Adult Aging and Culture on Theory of Mind. J Gerontol B Psychol Sci Soc Sci. 2022 Feb 3;77(2):332-340. doi: 10.1093/geronb/gbab093.
PMID: 34036302BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yook Chin Chia Professor, Datin, Dr, MBBS, FRCP
Sunway University
- STUDY CHAIR
Tin Tin Su
Monash University
- STUDY CHAIR
Rozainee Khairudin
The National University of Malaysia
- STUDY CHAIR
Nur Ain Shahrier
Sunway University
- STUDY CHAIR
Audrey Wei Ling Lim
Sunway University
Central Study Contacts
Yook Chin Chia Professor, Head of Department of Medical Sciences, MBBS; FRCP
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Head of Department of Medical Sciences, School of Medical and Life Sciences and Programme Leader of Postgraduate Diploma In Primary Care For Elderly
Study Record Dates
First Submitted
April 3, 2024
First Posted
April 19, 2024
Study Start
May 20, 2022
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2030
Last Updated
April 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
No. However, limited access to data could be shared upon reasonable request.